Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 4—April 2008
Research

Emericella quadrilineata as Cause of Invasive Aspergillosis

Paul E. Verweij*Comments to Author , János Varga†‡, Jos Houbraken†, Antonius J.M.M. Rijs*, Frans M. VerduynLunel*, Nicole M.A. Blijlevens*, Yvonne R. Shea§, Steven M. Holland§, Adilia Warris*, Willem J. G. Melchers*, and Robert A. Samson†
Author affiliations: *Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; †Centraal Bureau voor Schimmelcultures Fungal Biodiversity Centre, Utrecht, the Netherlands,; ‡University of Szeged, Szeged, Hungary; §National Institutes of Health, Bethesda, Maryland, USA;

Main Article

Table

Antifungal activities against Emericella nidulans and E. quadrilineata

Drug MIC, mean
Significance*
E. nidulans (n = 12) E. quadrilineata (n = 12)
Amphotericin B 2.5 0.5 p<0.05
Itraconazole 0.07 0.13 NS
Voriconazole 0.26 0.39 p<0.05
Posaconazole 0.25 0.22 p<0.05
Caspofungin† 0.32 1.83 p<0.05
Terbinafine 0.01 0.009 NS

*NS, not significant.
†Mean minimum effective concentration was compared.

Main Article

Page created: July 14, 2010
Page updated: July 14, 2010
Page reviewed: July 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external